======= ANKH ======= == Gene Information == * **Official Symbol**: ANKH * **Official Name**: ANKH inorganic pyrophosphate transport regulator * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56172|56172]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HCJ1|Q9HCJ1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANKH&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANKH|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605145|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a multipass transmembrane protein that is expressed in joints and other tissues and controls pyrophosphate levels in cultured cells. Progressive ankylosis-mediated control of pyrophosphate levels has been suggested as a possible mechanism regulating tissue calcification and susceptibility to arthritis in higher animals. Mutations in this gene have been associated with autosomal dominant craniometaphyseal dysplasia. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Regulates intra- and extracellular levels of inorganic pyrophosphate (PPi), probably functioning as PPi transporter. |ANKH| |inorganic diphosphate transmembrane transporter activity| |outer membrane| |phosphate ion transmembrane transporter activity| |inorganic diphosphate transport| |inorganic phosphate transmembrane transporter activity| |phosphate ion transmembrane transport| |phosphate ion transport| |regulation of bone mineralization| |regulation of biomineralization| |regulation of biomineral tissue development| |inorganic anion transmembrane transport| |inorganic anion transport| |regulation of ossification| |locomotory behavior| |anion transmembrane transport| |skeletal system development| |behavior| |anion transport| |inorganic ion transmembrane transport| |ion transmembrane transport| |transmembrane transport| |ion transport| |integral component of plasma membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-2.59| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-2.57| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-2.38| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-2.28| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.09| |[[:results:exp483|FTY720 3μM R08 exp483]]|-2.03| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-2| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.79| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|2.12| |[[:results:exp11|CCCP 1μM R00 exp11]]|2.48| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|2.68| ^Gene^Correlation^ |[[:human genes:c:cyb561a3|CYB561A3]]|0.536| |[[:human genes:h:hgc6.3|HGC6.3]]|0.461| |[[:human genes:i:ireb2|IREB2]]|0.429| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2214 * **Expression level (log2 read counts)**: 6.21 {{:chemogenomics:nalm6 dist.png?nolink |}}